Bcr-Abl (PHILADELPHIA) t(9 22) by FISH Test
50+ booked in last 3 daysTest Overview
This test is performed to detect the chromosomal abnormalities of the BCR and ABL1 genes involved in translocation t(9;22) associated with chronic myelogenous leukemia (CML), acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) using FISH.
Frequently Asked Questions
Fluorescence in situ hybridization (FISH) using BCR/ABL 1 probe is useful in the identification of the Philadelphia chromosome in patients with CML, ALL, or AML.
Doctors may prescribe this test in certain types of blood cancers like CML, ALL, AML for diagnosis and managenemt.
This test is performed to detect the chromosomal abnormalities of the BCR and ABL1 genes involved in translocation t(9;22) associated with chronic myelogenous leukemia (CML), acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) using FISH. FISH is useful in monitoring remission in patient, diagnosing leukemia; as a target of therapuetic drugs, to measure objective response to chemotherapyand also helps in decision making to increase drug dose or to change to a second-line treatment.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.